Therapeutic potential of cannabinoid receptor agonists as analgesic agents (Q36187065)

12 August 2017

1 reference

title

Therapeutic potential of cannabinoid receptor agonists as analgesic agents (English)

1 reference

12 August 2017

0 references

0 references

0 references

Stuart Bevan

2

0 references

author name string

Alyson Fox

series ordinal

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

14

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

695-703

1 reference

The effects of cannabinoids on the brain

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Therapeutic potential of cannabinoids in CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The endogenous cannabinoid system and its role in nociceptive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Cannabinoid receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The cannabinoid system and immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Cannabinoid receptors undergo axonal flow in sensory nerves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Nabilone in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

The perceived effects of smoked cannabis on patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Pain relief with oral cannabinoids in familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Pharmacological and biochemical interactions between opioids and cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Two distinctive antinociceptive systems in rats with pathological pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Ajulemic acid: A novel cannabinoid produces analgesia without a "high"

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.6.695

10.1517/13543784.14.6.695

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference